News and Trends 14 Feb 2023
Disc Medicine raises $62.5M for hematology programs
Disc Medicine, Inc., a U.S. clinical-stage biopharma company focused on the discovery, development and commercialization of treatments for patients suffering from serious hematologic diseases, has entered into a securities purchase…